glp-1/gip agonists TrimRX Dual GIP/GLP-1 receptor agonists: New
Description
Figure 8: Photograph of Professor Benjamin Moore as a young man, credit: Wellcome Library

The critical question is whether there is an association between the level to which GLP-1 increases and the period of that increment and extent of weight loss post MBS

Reports submitted to the FDA Adverse Event Reporting System have included insomnia, anxiety, nervousness, and depressive symptoms, 79 while the European Medicines Agency has flagged cases of depression, self-injury, and suicidal ideation among users of liraglutide or semaglutide

Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial

GLP-1 medications, by comparison, cost $800$1,200 per month, adding up to $10,000+ yearly, making surgery more cost-effective long-term

results are aligned with ours revealing that BMI reductions that were seen (1.147 kg/m 2 at 24 months) indicate that GLP-1 RA weight loss effects contribute to therapeutic advantages by reducing intracranial venous pressure and decreasing the generation of pro-inflammatory adipokines
